Skip to main content

Table 5 The analysis of mean peptide intensity per gene symbol for QSER1 protein by ANOVA with Tukey–Kramer multiple means comparison

From: The plasma peptides of breast versus ovarian cancer

TreatmentMeanSDData NTukey–Kramer
15.0727690.30298621d
24.5934090.51198967cde
34.6334970.328526bde
44.0563120.16103733a
55.9182120.76085125h
65.7175920.76334618h
74.8372760.2165738bdef
94.5426930.65645141ceg
104.6002090.64009766cde
114.5121030.5156318acde
124.02977404acde
134.4529350.49166450aceg
144.124790.35146935af
154.4193550.19876353ace
164.3242120.50453832ace
174.9288810.94731922dg
184.1734030.47833936ab
194.7403430.42814258cde
204.801510.47590735de
214.7495830.51368636cde
224.7555530.51711725cde
234.583920.46614711acde
243.73629304abc
254.8817610.95309818de
  1. Treatment ID numbers: 1, Alzheimer normal; 2, Alzheimer’s normal control STYP; 3, Alzheimer’s dementia; 4, Alzheimer’s dementia STYP; 5, Cancer breast; 6, Cancer breast STYP; 7, Cancer control; 8, Cancer control STYP; 9, Cancer ovarian; 10, Cancer ovarian STYP; 11, Ice Cold; 12, Ice Cold STYP; 13, Heart attack Arterial; 14 Heart attack Arterial STYP; 15, Heart attack normal control, 16, Heart attack normal Control STYP; 17, Heart attack; 18, Heart attack STYP; 19, Multiple Sclerosis normal control; 20, Multiple sclerosis normal control STYP; Multiple sclerosis; 22, Multiple Sclerosis STYP, 23 Sepsis; 24, Sepsis STYP; 25, Sepsis normal control; 26, Sepsis normal control STYP. The Tukey–Kramer multiple comparison ranking of mean intensity from R is shown by letters